Sidekick-1 Upregulation in Podocytes Induces FSGS by Disrupting MAGI-1 Function
足细胞中 Sidekick-1 上调通过破坏 MAGI-1 功能诱导 FSGS
基本信息
- 批准号:8115089
- 负责人:
- 金额:$ 33.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:ActininAdhesionsAdultAffectArchitectureBAIAP1 geneBindingBiopsy SpecimenCell Adhesion MoleculesCellsDataDefectDevelopmentDiseaseElectronsEnd stage renal failureFocal Segmental GlomerulosclerosisFunctional disorderGoalsHIVHealthHumanInjuryKidneyKnockout MiceLabelLeadMediator of activation proteinMicroscopicModelingMusNephrosisNephrotic SyndromePathogenesisPathway interactionsPhenotypePlayPredispositionProcessProteinsProteinuriaRenal glomerular diseaseReportingRodent ModelRoleStagingStructureTestingTimeTransgenic MiceTransgenic OrganismsUnited StatesUp-Regulationglomerulosclerosismouse modelnephrinnew therapeutic targetnovelnovel therapeuticsoverexpressionpodocyteslit diaphragmsynaptopodintherapeutic target
项目摘要
DESCRIPTION (provided by applicant): Focal and segmental glomerulosclerosis (FSGS) is a leading cause of nephrotic syndrome and end-stage renal disease worldwide. Although the mechanisms underlying this important disease are poorly understood, it is clear that the glomerular podocyte plays a central role in disease pathogenesis. In the current proposal, we demonstrate that the homophilic adhesion molecule sidekick-1 (sdk-1) is dramatically upregulated in podocytes in FSGS both in rodent models and in human kidney biopsy samples. We show that sdk-1 strongly interacts with the slit diaphragm linker protein MAGI-1, which is already known to interact with several critical podocyte proteins including synaptopodin, a-actinin-4, nephrin, JAM4, and ¿-catenin. Furthermore, transgenic mice with podocyte-specific overexpression of sdk-1 develop gradual proteinuria, nephrosis, and FSGS. Similarly, MAGI-1 deficient mice also develop gradually progressive proteinuria and FSGS. The similarities between the phenotypes of these two novel mouse models and the fact that the two involved proteins directly interact suggest that similar pathogenic factors may be involved in both models. We hypothesize that the overexpression of sdk-1 in podocytes in FSGS disrupts the ability of MAGI-1 to stabilize podocyte architecture and that over time this leads to the development of glomerular sclerosis. To confirm and identify the involved mechanisms, we propose three specific aims: 1) To determine how the overexpression of sdk-1 affects the binding of MAGI-1 to other critical podocyte proteins. 2) To characterize the renal phenotype of MAGI-1 null mice and to compare it to the phenotype of the podocyte-specific sdk-1 overexpression model. 3) To test the susceptibility of sdk-1 knockout mice to podocyte injury and to the development of FSGS. In this way, we will demonstrate that sdk-1 upregulation is an important factor contributing to the pathogenesis of FSGS and could represent a novel therapeutic target. PUBLIC HEALTH RELEVANCE: Focal and segmental glomerulosclerosis is the leading cause of idiopathic nephrotic syndrome in the United States and the most common cause of end stage renal disease caused by primary glomerular disease worldwide. In this project, we identify a novel mechanism that contributes greatly to the pathogenesis of this important disease and may lead to the identification of novel potential therapeutic targets.
描述(由申请人提供):局灶性节段性肾小球硬化症(FSGS)是全世界肾病综合征和终末期肾病的主要原因,尽管人们对这种重要疾病的机制知之甚少,但很明显肾小球足细胞起着核心作用。在当前的提议中,我们证明同源粘附分子 sidekick-1 (sdk-1) 在足细胞中显着上调。在啮齿动物模型和人类肾活检样本的 FSGS 中,我们表明 sdk-1 与缝隙隔膜连接蛋白 MAGI-1 强烈相互作用,已知 MAGI-1 与几种关键的足细胞蛋白相互作用,包括突触蛋白、a-actinin-4。 、去氧肾上腺素、JAM4 和 ¿此外,足细胞特异性过度表达 sdk-1 的转基因小鼠会逐渐出现蛋白尿、肾病和 FSGS,MAGI-1 缺陷小鼠也会逐渐出现进行性蛋白尿和 FSGS。这两种新型小鼠的表型之间存在相似之处。模型以及两种相关蛋白直接相互作用的事实表明,两种模型中可能涉及相似的致病因素,我们发现足细胞中 sdk-1 的过度表达。 FSGS 破坏了 MAGI-1 稳定足细胞结构的能力,随着时间的推移,这会导致肾小球硬化的发展。为了确认和确定所涉及的机制,我们提出了三个具体目标:1) 确定 sdk-1 的过度表达是如何发生的。影响 MAGI-1 与其他关键足细胞蛋白的结合 2) 表征 MAGI-1 缺失小鼠的肾脏表型,并将其与足细胞特异性 sdk-1 的表型进行比较。 3) 测试sdk-1敲除小鼠对足细胞损伤和FSGS发展的敏感性通过这种方式,我们将证明sdk-1上调是促进FSGS发病的重要因素。公共卫生相关性:局灶性和节段性肾小球硬化症是美国特发性肾病综合征的主要原因。以及全球原发性肾小球疾病引起的终末期肾病的最常见原因。在该项目中,我们确定了一种新机制,该机制对这种重要疾病的发病机制有很大贡献,并可能导致新的潜在治疗靶点的确定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lewis Kaufman其他文献
Lewis Kaufman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lewis Kaufman', 18)}}的其他基金
Podocyte-specific Rap1 agonism for treatment of glomerular disease
足细胞特异性 Rap1 激动剂治疗肾小球疾病
- 批准号:
10441968 - 财政年份:2022
- 资助金额:
$ 33.23万 - 项目类别:
Podocyte-specific Rap1 agonism for treatment of glomerular disease
足细胞特异性 Rap1 激动剂治疗肾小球疾病
- 批准号:
10588172 - 财政年份:2022
- 资助金额:
$ 33.23万 - 项目类别:
DACH1 transcriptomic regulation of glucocorticoid-responsive glomerular disease
DACH1 糖皮质激素反应性肾小球疾病的转录组调控
- 批准号:
10338127 - 财政年份:2020
- 资助金额:
$ 33.23万 - 项目类别:
DACH1 transcriptomic regulation of glucocorticoid-responsive glomerular disease
DACH1 糖皮质激素反应性肾小球疾病的转录组调控
- 批准号:
10551285 - 财政年份:2020
- 资助金额:
$ 33.23万 - 项目类别:
Sidekick-1 Upregulation in Podocytes Induces FSGS by Disrupting MAGI-1 Function
足细胞中 Sidekick-1 上调通过破坏 MAGI-1 功能诱导 FSGS
- 批准号:
8509679 - 财政年份:2009
- 资助金额:
$ 33.23万 - 项目类别:
Sidekick-1 Upregulation in Podocytes Induces FSGS by Disrupting MAGI-1 Function
足细胞中 Sidekick-1 上调通过破坏 MAGI-1 功能诱导 FSGS
- 批准号:
7695232 - 财政年份:2009
- 资助金额:
$ 33.23万 - 项目类别:
Sidekick-1 Upregulation in Podocytes Induces FSGS by Disrupting MAGI-1 Function
足细胞中 Sidekick-1 上调通过破坏 MAGI-1 功能诱导 FSGS
- 批准号:
8308636 - 财政年份:2009
- 资助金额:
$ 33.23万 - 项目类别:
Sidekick-1 Upregulation in Podocytes Induces FSGS by Disrupting MAGI-1 Function
足细胞中 Sidekick-1 上调通过破坏 MAGI-1 功能诱导 FSGS
- 批准号:
7912960 - 财政年份:2009
- 资助金额:
$ 33.23万 - 项目类别:
Sidekick proteins in HIV-associated nephropathy
HIV 相关肾病中的 Sidekick 蛋白
- 批准号:
7692402 - 财政年份:2005
- 资助金额:
$ 33.23万 - 项目类别:
Sidekick proteins in HIV-associated nephropathy
HIV 相关肾病中的 Sidekick 蛋白
- 批准号:
7039229 - 财政年份:2005
- 资助金额:
$ 33.23万 - 项目类别:
相似国自然基金
人胎盘水凝胶类器官贴片重建子宫内膜对重度宫腔粘连的作用及机制研究
- 批准号:
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
- 批准号:82302691
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ROS清除型动态粘附水凝胶的制备及其在声带粘连防治中的作用与机制研究
- 批准号:82301292
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于“胞宫藏泻”理论探讨补肾养营活血方和HuMSCs调节ERS介导的细胞焦亡重塑粘连宫腔内膜容受态的研究
- 批准号:82305302
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Talin1 Function in Cardiac Myofibroblasts
Talin1 在心肌成纤维细胞中的功能
- 批准号:
10310438 - 财政年份:2019
- 资助金额:
$ 33.23万 - 项目类别:
Disrupting FSGS1-associated Actin Assembly in Glomerulosclerosis
破坏肾小球硬化症中 FSGS1 相关肌动蛋白组装
- 批准号:
8479770 - 财政年份:2013
- 资助金额:
$ 33.23万 - 项目类别:
Actin Assembly at cadherin dependent adherens junctions
肌动蛋白在钙粘蛋白依赖性粘附连接处的组装
- 批准号:
8483248 - 财政年份:2013
- 资助金额:
$ 33.23万 - 项目类别:
Actin Assembly at cadherin dependent adherens junctions
肌动蛋白在钙粘蛋白依赖性粘附连接处的组装
- 批准号:
8683198 - 财政年份:2013
- 资助金额:
$ 33.23万 - 项目类别:
Traumatic brain injury: early mechanosensitive events in astrocytes
创伤性脑损伤:星形胶质细胞的早期机械敏感事件
- 批准号:
8722056 - 财政年份:2013
- 资助金额:
$ 33.23万 - 项目类别: